The lifetime risk of developing ovarian cancer (OC) is 39–44% for BRCA1 and up to 11–17% for BRCA2-mutated women, with an onset 5–10 years later [5,6,7,8] (Table 1). This evidence concerns the gene BRCA2 and ovarian carcinoma.